Cambridge Investment Research Advisors, Inc. Bausch Health Companies Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.9 Billion
- Q4 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 24,271 shares of BHC stock, worth $185,673. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,271
Previous 24,340
0.28%
Holding current value
$185,673
Previous $199,000
1.51%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding BHC
# of Institutions
270Shares Held
252MCall Options Held
5.12MPut Options Held
9.43M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$266 Million3.8% of portfolio
-
Goldentree Asset Management LP New York, NY27.5MShares$211 Million16.77% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$202 Million12.9% of portfolio
-
National Bank Of Canada15.4MShares$118 Million0.17% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$99.5 Million0.23% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.77B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...